help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DePaolo, L. V.
Right arrow Articles by Ling, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DePaolo, L. V.
Right arrow Articles by Ling, N.

Endocrinology, Vol 132, 2221-2228, Copyright © 1993 by Endocrine Society


ARTICLES

Increased follistatin (activin-binding protein) gene expression in rat anterior pituitary tissue after ovariectomy may be mediated by pituitary activin

LV DePaolo, M Mercado, Y Guo and N Ling
Department of Molecular Endocrinology, Whittier Institute for Diabetes and Endocrinology, La Jolla, California 92037.

For lack of evidence to the contrary, it is now believed that the FSH- suppressing actions of follistatin are due to its ability to bind endogenous pituitary activin. Recent data have demonstrated a role for pituitary activin-B in mediating FSH hypersecretion after ovariectomy (OVX) and during the secondary FSH surge on estrus. Therefore, given that follistatin is produced within anterior pituitary tissue, and considering the potentially important function of follistatin to modulate activin bioactivity, we sought to gain insights into the regulation of follistatin gene expression in the anterior pituitary gland of adult female rats. At the termination of all in vivo investigations, rats were killed, trunk blood was collected for determination of serum LH and FSH levels by RIA, and pituitary tissue was collected, pooled (two or three glands per pool), and processed for determination of follistatin messenger RNA (mRNA) levels by a solution- hybridization RNase protection assay. In the first experiment, pituitary follistatin mRNA levels were significantly (P < 0.01) increased 3 weeks after OVX. Treatment of long-term ovariectomized rats with a Nal-Glu LHRH antagonist restored serum LH levels to precastration levels and suppressed serum FSH concentrations by 70%, but follistatin message levels were not altered. In contrast, treatment of castrated rats with recombinant human follistatin-288 selectively suppressed serum FSH levels (50%) and completely abolished OVX-induced increases in follistatin mRNA levels. Subsequent experiments revealed that OVX-induced increases in follistatin gene expression could be observed in pituitary tissue grafted underneath the kidney capsule of hypophysectomized rats. Furthermore, follistatin mRNA levels were significantly (P < 0.05) higher in pituitary glands taken from estrous rats during the secondary FSH surge (0200 h) than in glands obtained from rats on proestrous morning when serum FSH levels were basal. Because increased steady state follistatin mRNA levels in the latter two instances were associated with selective FSH hypersecretion, and such hypersecretion was previously shown to be dependent to a significant degree on pituitary activin, we next tested the hypothesis that increased pituitary follistatin gene expression is mediated by activin. Using cultures of dispersed pituitary cells, addition of recombinant human activin-A for 72 h increased follistatin mRNA levels 3-fold while enhancing only FSH secretion. Collectively, the present results demonstrate a coupling of follistatin gene expression in the anterior pituitary gland with changes in pituitary FSH secretion under conditions where LH secretion is unaltered. Viewed in the context of previous work, the data also suggest that changes in follistatin mRNA levels may be linked to activin signaling.


This article has been cited by other articles:


Home page
Biol. Reprod.Home page
J. P. Moore ,Jr. and S. J. Winters
Weaning and the Developmental Changes in Follicle-Stimulating Hormone, Pituitary Adenylate Cyclase-Activating Polypeptide, and Inhibin B in the Male Rat
Biol Reprod, April 1, 2008; 78(4): 752 - 760.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Blount, J. M. Vaughan, W. W. Vale, and L. M. Bilezikjian
A Smad-binding Element in Intron 1 Participates in Activin-dependent Regulation of the Follistatin Gene
J. Biol. Chem., March 14, 2008; 283(11): 7016 - 7026.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
L. M Bilezikjian, A. L Blount, C. J Donaldson, and W. W Vale
Pituitary actions of ligands of the TGF-{beta} family: activins and inhibins.
Reproduction, August 1, 2006; 132(2): 207 - 215.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. A. Prendergast, L. L. Burger, K. W. Aylor, D. J. Haisenleder, A. C. Dalkin, and J. C. Marshall
Pituitary Follistatin Gene Expression in Female Rats: Evidence That Inhibin Regulates Transcription
Biol Reprod, February 1, 2004; 70(2): 364 - 370.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y.-G. Chen, H. M. Lui, S.-L. Lin, J. M. Lee, and S.-Y. Ying
Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin
Experimental Biology and Medicine, February 1, 2002; 227(2): 75 - 87.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Baratta, L.A. West, A.M. Turzillo, and T.M. Nett
Activin Modulates Differential Effects of Estradiol on Synthesis and Secretion of Follicle-Stimulating Hormone in Ovine Pituitary Cells
Biol Reprod, February 1, 2001; 64(2): 714 - 719.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. Ogawa, M. Funaba, L. S. Mathews, and T. Mizutani
Activin A Stimulates Type IV Collagenase (Matrix Metalloproteinase-2) Production in Mouse Peritoneal Macrophages
J. Immunol., September 15, 2000; 165(6): 2997 - 3003.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. C. Dalkin, D. J. Haisenleder, J. T. Gilrain, K. Aylor, M. Yasin, and J. C. Marshall
Gonadotropin-Releasing Hormone Regulation of Gonadotropin Subunit Gene Expression in Female Rats: Actions on Follicle-Stimulating Hormone {beta} Messenger Ribonucleic Acid (mRNA) Involve Differential Expression of Pituitary Activin ({beta}-B) and Follistatin mRNAs
Endocrinology, February 1, 1999; 140(2): 903 - 908.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. C. Dalkin, D. J. Haisenleder, J. T. Gilrain, K. Aylor, M. Yasin, and J. C. Marshall
Regulation of Pituitary Follistatin and Inhibin/Activin Subunit Messenger Ribonucleic Acids (mRNAs) in Male and Female Rats: Evidence for Inhibin Regulation of Follistatin mRNA in Females
Endocrinology, June 1, 1998; 139(6): 2818 - 2823.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. J. Winters, A. C. Dalkin, and T. Tsujii
Evidence That Pituitary Adenylate Cyclase Activating Polypeptide Suppresses Follicle-Stimulating Hormone-{beta} Messenger Ribonucleic Acid Levels by Stimulating Follistatin Gene Transcription
Endocrinology, October 1, 1997; 138(10): 4324 - 4329.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society